|
PRC1 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.415540E-02 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.831700E-02 |
| Normal-vs-Stage2 |
6.680400E-01 |
| Normal-vs-Stage3 |
4.673700E-02 |
| Normal-vs-Stage4 |
4.236900E-03 |
| Stage1-vs-Stage2 |
1.297980E-01 |
| Stage1-vs-Stage3 |
8.480400E-01 |
| Stage1-vs-Stage4 |
8.926400E-02 |
| Stage2-vs-Stage3 |
1.516630E-01 |
| Stage2-vs-Stage4 |
1.741750E-02 |
| Stage3-vs-Stage4 |
1.388640E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
7.078800E-03 |
| Normal-vs-AfricanAmerican |
6.857500E-02 |
| Normal-vs-Asian |
5.421900E-02 |
| Caucasian-vs-AfricanAmerican |
6.898800E-01 |
| Caucasian-vs-Asian |
9.567800E-01 |
| AfricanAmerican-vs-Asian |
7.272800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.108080E-02 |
| Normal-vs-Female |
2.483700E-02 |
| Male-vs-Female |
1.688600E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
7.916500E-03 |
| Normal-vs-Age(41-60Yrs) |
1.837040E-01 |
| Normal-vs-Age(61-80Yrs) |
6.141900E-02 |
| Normal-vs-Age(81-100Yrs) |
1.027840E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.671550E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.870600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.401600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.535400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.506420E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.042400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
4.465400E-01 |
| Classical-VS-Follicular |
1.92175000000017E-05 |
| Classical-VS-Other |
8.510800E-01 |
| Classical-VS-Normal |
1.584060E-03 |
| Tall-VS-Follicular |
1.363550E-03 |
| Tall-VS-Other |
5.713200E-01 |
| Tall-VS-Normal |
7.639200E-03 |
| Follicular-VS-Other |
2.219600E-01 |
| Follicular-VS-Normal |
8.368200E-01 |
| Other-VS-Normal |
3.045400E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.325550E-01 |
| Normal-vs-N1 |
6.648000E-02 |
| N0-vs-N1 |
5.212800E-01 |
|
|
